The Walter and Eliza Hall Institute of Medical Research Public Companylimited By Guarantee

The Walter and Eliza Hall Institute of Medical Research Public Companylimited By Guarantee is a research organisation in Parkville, Australia that has taken part in 5 EU-funded projects since 2016.

EU funding receivedNot recorded
EU projects5
As coordinator0
Running now3
First EU project2016
Latest project2025
CountryAustralia
EU registration (PIC)954560414
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are The Walter and Eliza Hall Institute of Medical Research Public Companylimited By Guarantee's own share of each project, not the project's full budget.

  • Horizon Europe€0 · 4 projects
  • Horizon 2020€0 · 1 project

Projects

5 EU-funded projects, newest first. Each links to the official record.

  • PvSeroRDTAssociated partner

    A point-of-care serological rapid diagnostic test for risk of Plasmodium vivax hypnozoite infection (PvSeroRDT)

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • ENT1DEPAssociated partner

    ENTEROVIRUS-LINKED TYPE 1 DIABETES EXPOSED -MECHANISMS AND PREVENTION

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

  • CoMAnDAssociated partner

    Contribution of the Epstein-Barr Virus and the Tumour Microenvironment to Anti-Apoptotic Mechanisms in DLBCL

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

  • PvSTATEMAssociated partner

    SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADAGASCAR TO A MOBILE-TECHNOLOGY SUPPORTED INTERVENTION

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

  • BRCANCERPartner

    A novel approach for modeling development of breast cancer

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antivirals
  • breast cancer
  • diabetes
  • gene therapy
  • genetic engineering
  • immunology
  • malaria
  • oncology
  • personalized medicine
  • proteins
  • public health
  • stem cells
  • transplantation
  • vaccines

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime